On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
Every one of us has quoted a healing rate. In clinic, in a grant, in a talk, in a conversation with a patient sitting on the exam table asking the only question that matters: will this close? Most of those quoted numbers came from the control arms of industry trials, which is a bit like... Continue Reading →
Two diabetic foot data engines published the same day on two continents. STEADY (US) is a 5,000-patient, AI-enabled real-world registry; DARE-DiaFoot (Italy) is a deep, multi-instrumental phenotyping protocol that quietly studies remission. One is the census, the other the core sample. Together with EURODIALE, the U.S. Wound Registry, and the National Diabetes Foot Care Audit, they sketch a blueprint for finally measuring what we manage.
Important, revealing work from Emory's diabetic foot team featuring Marcos Schechter from a county hospital system. Background: There are limited data on post-hospital discharge clinic attendance rates and outcomes among patients with diabetic foot ulcers (DFUs). Methods: Retrospective study of patients hospitalized with a DFU from 2016 to 2019 in a large public hospital. We measured rates... Continue Reading →
